UNC Lineberger News

Dr. Hy Muss Named a 2012 Brinker Award winner for scientific distinction

Dr. Hy Muss Named a 2012 Brinker Award winner for scientific distinction

DALLAS -- An American clinician-scientist and an Israeli researcher whose work has led to more personalized treatments for breast cancer are being honored as this year’s winners of the prestigious Susan G. Komen for the Cure® Brinker Awards for Scientific Distinction in Basic Science and Clinical Research, the highest awards of merit given by the world’s leading breast cancer organization.

Dr. Hy Muss Named a 2012 Brinker Award winner for scientific distinction - Read More…

Damania, Dittmer talk about new global oncology program

Blossom Damania, PhD, and Dirk Dittmer, PhD, both have lived all over the world, where they saw firsthand the global burden of cancer. Both are professors of microbiology and immunology in the UNC school of Medicine and members of UNC Lineberger.

Damania, Dittmer talk about new global oncology program - Read More…

Evans talks about DNA analysis on HuffPost Live

Evans talks about DNA analysis on HuffPost Live

James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, provided his perspective on a HuffPost Live broadcast that aired on September 24, 2012.

Evans talks about DNA analysis on HuffPost Live - Read More…

Carey named Division Chief of Hematology-Oncology and Physician-in-Chief of the N.C. Cancer Hospital

Chapel Hill - Lisa A. Carey, MD, has been appointed Chief of the Division of Hematology and Oncology at the University of North Carolina School of Medicine and Physician-in-Chief of the N.C. Cancer Hospital.

Carey named Division Chief of Hematology-Oncology and Physician-in-Chief of the N.C. Cancer Hospital - Read More…

Informatics approach helps doctors, patients make sense of genome data

Informatics approach helps doctors, patients make sense of genome data

Chapel Hill, NC – The cost of sequencing the entire human genome, or exome – the regions of the genome that are translated into proteins that affect cell behavior – has decreased significantly, to the point where the cost of looking at the majority of a patient’s genomic data may be less expensive than undertaking one or two targeted genetic tests.

Informatics approach helps doctors, patients make sense of genome data - Read More…

Diseases of aging map to a few ‘hotspots’ on the human genome

Chapel Hill, NC –Researchers have long known that individual diseases are associated with genes in specific locations of the genome.

Diseases of aging map to a few ‘hotspots’ on the human genome - Read More…

NPR series focuses on gene sequencing, Evans comments

NPR series focuses on gene sequencing, Evans comments

James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in NPR's second story in its "$1,000 Genome" series, which aired today.

NPR series focuses on gene sequencing, Evans comments - Read More…

Cell death mystery yields new suspect for cancer drug development

Cell death mystery yields new suspect for cancer drug development

Chapel Hill, NC – A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development.

Cell death mystery yields new suspect for cancer drug development - Read More…

Whitehurst represents UNC Lineberger at SU2C telecast

Whitehurst represents UNC Lineberger at SU2C telecast

Dr. Angelique Whitehurst, assistant professor of pharmacology, was awarded a 2011 Innovative Research Grant from Stand Up to Cancer, the scientific partner of the American Association of Cancer Research.

Whitehurst represents UNC Lineberger at SU2C telecast - Read More…

TCGA discovers potential therapeutic targets for lung squamous cell carcinoma

TCGA discovers potential therapeutic targets for lung squamous cell carcinoma

Changes in DNA that are important to the initiation and progression of lung cancer also identified by NIH-supported researchers

TCGA discovers potential therapeutic targets for lung squamous cell carcinoma - Read More…

Cancer survivor Wanda Wooten shares her story

Cancer survivor Wanda Wooten shares her story

Wanda Wooten talks with NBC 17 about the day she was diagnosed with ovarian cancer and her treatment and offers encouragement to other women facing ovarian cancer.

Cancer survivor Wanda Wooten shares her story - Read More…

Cancer gene family member functions key to cell adhesion and migration

The WTX gene is mutated in approximately 30 percent of Wilms tumors, a pediatric kidney cancer. Like many genes, WTX is part of a family. In this case, WTX has two related siblings, FAM123A and FAM123C.

Cancer gene family member functions key to cell adhesion and migration - Read More…

ENCODE scientists show how DNA blueprint functions

ENCODE scientists show how DNA blueprint functions

UNC scientists were co-principal investigators and collaborators for projects described in the September 6, 2012 special issue of the journal Nature describing the ENCODE (Encyclopedia of DNA Elements) Project.

ENCODE scientists show how DNA blueprint functions - Read More…

Researchers license new technology

GeneCentric now has two separate exclusive licenses to diagnostic technologies from the University of North Carolina at Chapel Hill. The company was co-founded in 2011 by UNC Lineberger researchers Drs. Charles Perou and Neil Hayes, who discovered molecular signatures critical in distinguishing clinically relevant subtypes of lung cancer.

Researchers license new technology - Read More…

Carolina cracks top 10 in federal R&D expenditures

UNC-Chapel Hill rose to ninth from 16th among leading private and public research universities for the level of federal funding ($545.99 million) devoted to research and development in all fields during fiscal 2010.

Carolina cracks top 10 in federal R&D expenditures - Read More…

UNC headlines American Cancer Society breakfast

UNC headlines American Cancer Society breakfast

UNC Head Basketball Coach Roy Williams and UNC Lineberger physician-scientist Kim Rathmell, MD, PhD, were featured speakers at the American Cancer Society’s Cancer Action Network breakfast, held August 24th in Research Triangle Park.

UNC headlines American Cancer Society breakfast - Read More…

Program offers outdoor adventures to cancer survivors, UNC faculty volunteer services

Kayaking and rock climbing aren’t usual clinical activities for UNC Lineberger medical oncologist Dr. Juneko Grilley-Olson and nurse practitioner Elizabeth Sherwood, but they were during the time that each volunteered for a First Descents camp week for young adult cancer survivors.

Program offers outdoor adventures to cancer survivors, UNC faculty volunteer services - Read More…

Study reveals new molecular target for melanoma treatment

Study reveals new molecular target for melanoma treatment

Chapel Hill, NC – A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood.

Study reveals new molecular target for melanoma treatment - Read More…

The V Foundation selects UNC team as 2012 translational grant recipients

The V Foundation selects UNC team as 2012 translational grant recipients

The V Foundation for Cancer Research, one of the nation’s leading cancer research foundations, has awarded a $600,000 grant to a UNC Lineberger team.

The V Foundation selects UNC team as 2012 translational grant recipients - Read More…

B Cell survival holds key to chronic graft vs. host disease

B Cell survival holds key to chronic graft vs. host disease

Chapel Hill, NC – Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their long-term survival.

B Cell survival holds key to chronic graft vs. host disease - Read More…

Kathy DeClue: a selfless gift from a younger brother

A Randolph County woman with leukemia receives stem cells from her youngest brother in hopes of restoring her health and returning to work as a baker.

Kathy DeClue: a selfless gift from a younger brother - Read More…

Making the case for adjuvant chemotherapy for older patients with colon cancer

Making the case for adjuvant chemotherapy for older patients with colon cancer

Hy Muss, MD, and Debra Bynum, MD, co-authored an editorial in the July 20, 2012 issue of the Journal of Clinical Oncology.

Making the case for adjuvant chemotherapy for older patients with colon cancer - Read More…

UNC team describes novel inflammatory protein function

UNC team describes novel inflammatory protein function

A UNC-led team of scientists describes the function of a previously uncharacterized protein that dramatically influences inflammation.

UNC team describes novel inflammatory protein function - Read More…

UNC Lineberger announces first Marci Kramish Campbell Dissertation Award recipient

UNC Lineberger announces first Marci Kramish Campbell Dissertation Award recipient

Chapel Hill, NC – Carmina G. Valle, MPH, is the recipient of the first Marci Kramish Campbell Dissertation Award, a competitive $5,000 award to recognize excellence in dissertation research focused on cancer and the population sciences.

UNC Lineberger announces first Marci Kramish Campbell Dissertation Award recipient - Read More…

DeSimone gives podcast interview to EarthSky

Joseph DeSimone, PhD, Chancellor's Eminent Professor of Chemistry, gave an interview to EarthSky regarding his green inventions, his current work and the future of science.

DeSimone gives podcast interview to EarthSky - Read More…

McCrory earns medal at Olympic games

Nick McCrory, the son of Ana and Doug McCrory, won a bronze medal in the Olympic men’s 10-meter synchronized diving competition with partner David Boudia. Nick’s mother, Ana, works in the UNC Lineberger Tissue Culture Facility.

McCrory earns medal at Olympic games - Read More…

Evans discusses company's request for FDA approval of personalized DNA test

Evans discusses company's request for FDA approval of personalized DNA test

James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in an article on NPR's website discussing a recent request by a genetic test maker for the Food and Drug Administration to approve its personalized DNA test.

Evans discusses company's request for FDA approval of personalized DNA test - Read More…

UNC team reports a novel DNA Damage-Dependent Tumor Suppressor

UNC team reports a novel DNA Damage-Dependent Tumor Suppressor

Life is full of choices, and even cells come to a fork in the road. They have to decide what to do about damage to their DNA: repair the damage, force the damaged cell to die, or allow the damage to transform the cell to a tumor cell.

UNC team reports a novel DNA Damage-Dependent Tumor Suppressor - Read More…

UNC graduate students awarded Howard Hughes Medical Institute Fellowships

Three UNC graduate students were awarded International Predoctoral Fellowships by the Howard Hughes Medical Institute. Onur Dagliyan, Alakananda Das, and Mira Pronobis each received a $43,000 fellowship.

UNC graduate students awarded Howard Hughes Medical Institute Fellowships - Read More…

UNC Lineberger scientists receive grant for pulmonary inflammation research

UNC Lineberger scientists receive grant for pulmonary inflammation research

Three UNC Lineberger researchers are collaborating on a project recently awarded more than $3.3 million over five years from the National Institutes of Health’s National Heart, Lung, and Blood Institute.

UNC Lineberger scientists receive grant for pulmonary inflammation research - Read More…

Human papillomavirus types do not replace others after large-scale vaccination

Vaccines against human papillomavirus (HPV) are now recommended by the Centers for Disease Control and Prevention for both teenage boys and girls. The vaccine protects against the two most common types of the virus that cause cervical cancer: HPV 16 and 18. Is there a chance that the increased number of people vaccinated might result in an increase of other types of HPV that cause cancer?

Human papillomavirus types do not replace others after large-scale vaccination - Read More…

Diving into the Summer Olympics, UNC Lineberger employee's special connection

Diving into the Summer Olympics, UNC Lineberger employee's special connection

Ana McCrory of the Tissue Culture Facility will be making a special trip to London in July. She, her husband, Doug, their son, Lucas, and other family members are traveling to cheer on her son, Nick, who is a member of the 11-member US diving team for the 2012 Summer Olympics.

Diving into the Summer Olympics, UNC Lineberger employee's special connection - Read More…

Dittmer selected to serve as chair of AIDS-Associated Opportunistic Infections and Cancer Study Section

Dittmer selected to serve as chair of AIDS-Associated Opportunistic Infections and Cancer Study Section

Dirk Dittmer, PhD, professor of microbiology and immunology, has been selected to serve as chair of the AIDS-Associated Opportunistic Infections and Cancer Study Section, for the Center for Scientific Review, a program of the National Institutes of Health.

Dittmer selected to serve as chair of AIDS-Associated Opportunistic Infections and Cancer Study Section - Read More…

“Corona Cares” supports patients, families dealing with cancer

RALEIGH, NC – Crown Imports announced today that the highly successful “Corona Cares” charitable donation program in North Carolina will kick off on August 1 to benefit patient and family support programs at the N.C. Cancer Hospital. Over the past two years, “Corona Cares” has provided more than $210,000 for these programs.

“Corona Cares” supports patients, families dealing with cancer - Read More…

Study shows colon and rectal tumors constitute a single type of cancer

The Cancer Genome Atlas generates genomic data for colon and rectal cancers that point to potential targets for treatment.

Study shows colon and rectal tumors constitute a single type of cancer - Read More…

Kenan Institute appoints Joseph DeSimone as new director

Kenan Institute appoints Joseph DeSimone as new director

The University of North Carolina at Chapel Hill’s Frank Hawkins Kenan Institute of Private Enterprise has appointed Joseph M. DeSimone as its new director.

Kenan Institute appoints Joseph DeSimone as new director - Read More…

Cancer one of three UNC specialties nationally ranked by U.S. News

Overall, eleven specialties at UNC Hospitals were recognized as nationally ranked or high performing by U.S. News & World Report in its annual "America's Best Hospitals" issue.

Cancer one of three UNC specialties nationally ranked by U.S. News - Read More…

Pox, patents and pancreatic cancer vaccines

Pox, patents and pancreatic cancer vaccines

Rachel Roper, PhD, Associate Professor of Microbiology & Immunology at East Carolina’s Brody School of Medicine has been granted a patent for her discovery of a poxvirus gene that, when deleted, significantly weakens the vaccine virus while simultaneously increasing immune responses to it.

Pox, patents and pancreatic cancer vaccines - Read More…

Amos quoted in ABC News feature

Amos quoted in ABC News feature

Keith Amos, MD, assistant professor of surgery at UNC-Chapel Hill, is quoted in an ABC News feature discussing a new study about partial breast removal surgery to treat cancer.

Amos quoted in ABC News feature - Read More…

Strader honored by Leukemia & Lymphoma Society

Strader honored by Leukemia & Lymphoma Society

John Strader, PA-C with the hematologic malignancies program, was honored as the 2012 Man of the Year by the Leukemia & Lymphoma Society, North Carolina chapter, raising over $30,000 for the organization.

Strader honored by Leukemia & Lymphoma Society - Read More…